![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » EMA Sets Up Infrastructure for Monitoring COVID-19 Treatments and Vaccines
EMA Sets Up Infrastructure for Monitoring COVID-19 Treatments and Vaccines
![EMA_Logo.gif](https://www.fdanews.com/ext/resources/test/Drug-Images3/EMA_Logo.gif?t=1579219264&width=430)
The European Medicines Agency (EMA) has set up an infrastructure in collaboration with public and private partners to help monitor COVID-19 vaccines and treatments as soon as they are authorized.
The agency chose Utrecht University and the University Medical Center Utrecht as coordinators of the COSIGN project, aimed at monitoring COVID-19 vaccines and treatments in pregnant women. It partnered with IQVIA in June to build a framework for conducting multicenter cohort studies on the use of medicines for COVID-19 patients.
The EMA commissioned the ACCESS project with Utrecht University in May to study data sources and methods that can be used for the postmarketing evaluation of COVID-19 vaccines.
Upcoming Events
-
21Oct